Tinnitus, the perception of a phantom auditory sensation, is a frequent phenomenon that can be very distressing if experienced constantly. Although there are many treatments available for one to manage their experiences of tinnitus, there is currently no causal treatment for tinnitus, and specifically there is no “pill for tinnitus” which reduces or even abolishes tinnitus symptoms, even though this would be the preferred treatment approach for most sufferers.

A future drug against tinnitus may only have a certain effect on tinnitus, and not abolish the phantom sounds completely. Moreover, any drug against tinnitus will influence neural function and might thus have side effects. It is thus important to know about tinnitus sufferers’ expectations for a pill against tinnitus.

Researchers at the UCL Ear Institute want to find out how much of a change in their tinnitus people would like to experience at least, i.e. the minimum effect that they would like to see, in order to be satisfied with the drug. This may then guide the development of future drugs and be used to evaluate whether the effects against tinnitus are sufficient.

Please note that the UCL Ear Institute team are not developing a drug themselves.

In this study, the required information about tinnitus sufferers’ expectations for a drug against tinnitus will be collected using an online-based questionnaire.

What is involved?

All participants are asked to complete an online questionnaire, divided into 2 sections.

Section 1 - background information – your age, gender, hearing status, tinnitus duration and previous tinnitus treatments

Section 2 - consists of a questionnaire about your tinnitus. Each question will be asked twice.

First (a) to find out about your current experience of tinnitus, and secondly (b) to find out about the minimum amount of change you would want to see in your tinnitus after taking a pill, in order for you to feel that you are satisfied with the pill. 

In total, completing the questionnaire should take about 15 minutes of your time.

Who can take part?

Adults with chronic tinnitus. By chronic tinnitus we mean tinnitus that has been experienced for more than 6 months, either constant ot intermittent (occurring regularly and lasting for more than five minutes).

Who cannot take part?

Anyone not experiencing tinnitus, or  who has infrequent episodes of tinnitus.

Do I have to take part?

Taking part in this study is voluntary and is therefore your decision as to whether you would like to participate or not. You may also withdraw from the study at any time simply by stopping to answer the questionnaire and closing your browser window. Incomplete responses will be deleted.

Benefits and limitations to taking part

As the study focuses more on future improvements to the treatment of tinnitus, there are no direct benefits or limitations for participants. However, your response may help with future research into a tinnitus pill.

I'd like to take part!

Click on the button to be taken to the survey:

SURVEY

 

Data Protection and Privacy

This is an anonymous online study; you will not be required to provide your personal details. You will not be able to be identified in any ensuing reports or publications. For more information, please consult

https://www.ucl.ac.uk/legal-services/privacy/ucl-general-privacy-notice-participants-and-researchers-health-and-care-research-studies

and

https://www.ucl.ac.uk/legal-services/privacy/ucl-general-research-participant-privacy-notice

PLEASE NOTE:

That neither the researchers nor the UCL Ear Institute is connected to any tinnitus drug development, and are not aware of any specific tinnitus drug development. The study is just probing expectations for such a drug to inform potential drug developments of the aspects of tinnitus relief that are the most pressing.

Updated 22 May 2020